Longevity Science • Category 14 · New

Joint pain is never just wear and tear.

The traditional view holds that osteoarthritis and joint pain are simply the result of mechanical wear — of use, of years, of accumulated effort. But modern aging science understands that joints do not age in isolation. They age within an entire organism. Here: the biology that explains why some people walk pain-free at 70 and others have a destroyed joint at 45 — through the hallmarks of aging (López-Otín 2023), inflammaging, cellular senescence, mitochondrial dysfunction and functional medicine.

Why do some people in their 70s maintain excellent mobility while others develop severe pain at 45 or 50?

Millions believe joint pain is only a wear problem. "It's age", "it's use", "it's genetic, nothing can be done". That simple narrative runs through clinics, manuals and coffee-shop conversations. And while it captures part of the truth — mechanical load matters, previous injuries matter, biomechanics matters — it is profoundly incomplete.

If joint pain were just wear, the biological clock would run identically in everyone. The clinical reality is that two patients of the same age, same profession, with nearly identical MRIs, can have completely different trajectories: one lives with chronic limiting pain; the other walks, travels, works, medication-free. The answer is not only in the joint. It is in the organism that surrounds it — and in the biological mechanisms of systemic aging that organism is experiencing.

"Joints do not age in isolation. They are part of an entire organism."

The joint is the victim, not always the cause

Cartilage, subchondral bone, ligaments, menisci, synovial membrane — every joint tissue — is living tissue that responds to the organism's biological environment. It does not age in a bubble. Every chondrocyte, osteocyte, type A or B synoviocyte exists within a systemic milieu defined by cytokines, hormones, circulating glucose and fatty acids, available mitochondrial oxygen, and senescent signaling reaching it via the bloodstream.

Think of an iceberg. Pain is the visible tip — the symptom the patient reports, what shows on MRI, what the VAS measures. But beneath, vaster and silent, lies the set of biological mechanisms deteriorating tissue repair capacity years before the first symptom appears: chronic low-grade inflammation, mitochondrial dysfunction, senescent cell accumulation, insulin resistance, sarcopenia, hormonal dysregulation. Treating only the visible pain is like trimming the iceberg's tip while ignoring the nine-tenths submerged below.

Treating only the visible pain is like trimming the iceberg's tip while ignoring the nine-tenths submerged.
Ch. 03 · The true accelerators of joint aging

The eight accelerators the joint does not produce — but that destroy it

None of these mechanisms originate within the joint. All originate outside — in visceral adipose tissue, muscle, mitochondria, hormonal system, systemic inflammatory milieu — and reach cartilage through circulation. They are the invisible modulators of joint aging. Modern aging science — defined by Kennedy et al. in Cell (2014) as geroscience — integrates them as a single systemic reading.

  • 01 · Inflammaging

    Chronic low-grade inflammation

    Franceschi and Campisi (J Gerontol 2014) coined inflammaging to describe the systemic low-grade inflammation characteristic of aging. Furman et al. (Nature Medicine 2019) consolidated it as a shared causal factor in most age-related diseases — including osteoarthritis. Persistently elevated IL-6, TNF-α, IL-1β, hsCRP degrade cartilage matrix and alter chondrocyte function.

  • 02 · Insulin resistance

    Glucotoxicity and AGEs

    Berenbaum (Ann Rheum Dis 2011) described "diabetes-induced osteoarthritis" as a new phenotype. Chronic hyperglycemia generates advanced glycation end-products (AGEs) that stiffen joint collagen. Hyperinsulinemia activates pro-inflammatory signaling. Insulin resistance compromises IGF-1-dependent tissue repair.

  • 03 · Visceral fat excess

    Pro-inflammatory adipokines

    Berenbaum et al. (Curr Opin Rheumatol 2013): visceral adipose tissue is an endocrine organ that produces leptin, resistin, IL-6, TNF-α. That's why patients with central obesity develop joint pain even in non-load-bearing joints — the hands. Osteoarthritis is not only a weight-on-knee problem; it is systemic inflammation on every joint.

  • 04 · Mitochondrial dysfunction

    Insufficient ATP to repair

    Blanco, Rego and Ruiz-Romero (Nat Rev Rheumatol 2011) reviewed the central role of mitochondrial dysfunction in osteoarthritis. The chondrocyte requires mitochondrial ATP to synthesize matrix, maintain endogenous antioxidants and withstand oxidative stress. Dysfunctional mitochondria = less repair, more free radicals, more senescence.

  • 05 · Sarcopenia

    Loss of muscle mass

    The European EWGSOP2 consensus (Cruz-Jentoft et al., Age Ageing 2019) defines sarcopenia as progressive loss of muscle mass, strength and function. Periarticular muscle is stabilizer, shock absorber and endocrine pump — releasing anti-inflammatory myokines (irisin, IL-15). Less muscle = more direct load on the joint, less repair signaling, more inflammaging.

  • 06 · Chronic stress and cortisol

    Inflammation and catabolism

    Chronic HPA axis activation elevates basal cortisol, disturbing the circadian rhythm of inflammation. Chronically elevated cortisol is catabolic: degrades matrix, inhibits collagen synthesis, deteriorates muscle mass and exacerbates insulin resistance. It functions as a multiplier of the other accelerators.

  • 07 · Hormonal alterations

    Estrogens · testosterone · DHEA · GH

    Roman-Blas et al. (Arthritis Res Ther 2009) documented the role of estrogen deficiency in post-menopausal osteoarthritis. Estrogens preserve chondrocytes. Testosterone and DHEA modulate muscle mass and inflammatory response. IGF-1 and GH are major cartilage repair signals. Menopause and andropause objectively accelerate joint aging.

  • 08 · Cellular senescence

    SASP and local propagation

    Jeon et al. (Nat Med 2017) demonstrated that local clearance of senescent cells attenuates post-traumatic osteoarthritis progression. Coryell, Diekman and Loeser (Nat Rev Rheumatol 2021) reviewed the mechanism comprehensively: senescent cells secrete SASP (Senescence-Associated Secretory Phenotype) — cytokines, chemokines, metalloproteases — that destroys matrix and propagates senescence to neighboring cells.

Why two patients with the same MRI can live completely different trajectories

Structural imaging — MRI, X-ray — captures the geometry of joint damage: cartilage thickness, osteophytes, effusion, meniscal tear. What it does not capture is the biological context in which that geometry exists. Two patients with Kellgren-Lawrence III tricompartmental OA can have biological ages that differ by 15 years, opposite inflammatory profiles, and repair capacities belonging to entirely different categories.

Illustrative · Same radiological finding

Patient A · Patient B — the picture is identical. The biology, not.

Both are 55. Both have Kellgren-Lawrence grade III knee OA. Both consult for the same pain level. The difference does not appear on the MRI — it appears in systemic biomarkers. This is the dissociation between structure and biology that defines modern joint medicine.

  • Patient A · Biological age

    DunedinPACE ~0.85 (decelerated)

    The epigenetic aging rate measured by DunedinPACE is below average. Telomeres preserved. GlycanAge within expected range. Biological clock running slower than chronological.

  • Patient B · Biological age

    DunedinPACE ~1.18 (accelerated)

    Same chronological patient, biologically aging ~18% faster. GlycanAge suggests elevated systemic inflammation. Global repair capacity is objectively compromised — and cartilage pays the price.

  • Patient A · Inflammaging

    hsCRP 0.7 · IL-6 1.2 pg/mL

    Low systemic inflammatory markers. The blood milieu is relatively "clean" for the cartilage. Chondrocytes receive fewer circulating catabolic signals.

  • Patient B · Inflammaging

    hsCRP 3.8 · IL-6 4.6 pg/mL

    Persistent systemic inflammation. Every hour of the day, the circulating milieu bathes cartilage with catabolic cytokines. Repair does not fail for lack of time — it fails because of a hostile biochemical environment.

  • Patient A · Muscle mass

    ASMI 8.1 kg/m² (preserved)

    Appendicular skeletal muscle index within range. Quadriceps and periarticular stabilizers function as dynamic shock absorbers and myokine emitters. The joint receives both protection and repair signaling.

  • Patient B · Muscle mass

    ASMI 6.4 kg/m² (sarcopenia)

    Objective sarcopenia. Less dynamic shock absorption, more direct load on the cartilage, and fewer anti-inflammatory myokines circulating. Lost muscle no longer protects or signals repair.

  • Patient A · Metabolism

    HOMA-IR 1.2 · HbA1c 5.2%

    Insulin sensitivity preserved. No significant glucotoxicity. Minimal AGE accumulation on joint collagen. IGF-1 reparative signaling remains available.

  • Patient B · Metabolism

    HOMA-IR 4.3 · HbA1c 6.4%

    Insulin resistance and prediabetes. Glucotoxicity stiffening collagen. AGEs accumulating. Berenbaum defined this as "diabetes-induced osteoarthritis" — a metabolic phenotype of joint disease.

The MRI of both patients will show eroded cartilage, subchondral cysts and reduced joint space. The bodies of both patients, however, are living different trajectories. Progression speed, response to interventions, reported pain and functional capacity are not functions of the image — they are functions of biology. That is why an MRI, indispensable as it is, is never the complete picture.

The MRI captures geometry. Biology captures the trajectory.
Ch. 05 · Modern joint health evaluation

What really should be measured in a modern joint health evaluation

Beyond X-ray and MRI — which remain indispensable — modern evaluation integrates 11 categories of biological information that reconstruct the organism's repair context. This is the picture structural imaging does not show. The Advanced Biomarkers category describes the specific panels we use to quantify each dimension.

  • Biological age

    DunedinPACE · GlycanAge · TruAge

    Measures the real rate at which the organism is aging — independent of chronological age. It is the macro indicator integrating every other dimension.

  • DEXA + body composition

    Muscle mass · visceral fat · BMD

    Quantifies appendicular muscle mass (ASMI), visceral fat and bone mineral density. Sarcopenia and osteoporosis share mechanisms with osteoarthritis — and all three accelerate one another.

  • Inflammatory markers

    hsCRP · IL-6 · TNF-α · ESR

    Quantify inflammaging — the chronic inflammatory milieu bathing tissues. Furman et al. (Nat Med 2019) consolidated its causal role in age-related diseases.

  • Metabolic function

    HOMA-IR · HbA1c · ApoB · Lp(a)

    Insulin sensitivity and lipid profile. Berenbaum's "metabolic osteoarthritis" identified the prediabetes/diabetes cluster as a distinct phenotype of joint disease.

  • Full hormonal profile

    Estradiol · testosterone · DHEA-S · GH/IGF-1 · TSH

    Anabolic hormones (testosterone, estradiol, DHEA, GH/IGF-1) are major repair signals. Their age-related decline objectively accelerates cartilage, bone and muscle deterioration.

  • VO₂ Max

    Cardiorespiratory capacity

    The single most robust predictor of functional longevity. High VO₂ Max = working mitochondria, abundant capillarization, oxygen available to tissues — including cartilage and periarticular muscle.

  • Functional capacity

    Grip strength · gait speed

    Major functional markers. Grip strength and gait speed are 10-year mortality and mobility predictors. They reflect real muscle-joint integration.

  • Telomere length

    Telomere length

    Classic hallmarks-of-aging marker. Short telomeres correlate with replicative senescence — and with reduced capacity of chondral and muscular progenitors to repair damaged tissue.

  • Joint biomarkers

    CTX-II · COMP · CPII

    Biochemical markers of cartilage turnover. CTX-II reflects type II cartilage degradation, COMP reflects matrix turnover, CPII reflects synthesis. They detect biochemical changes before radiological imaging.

  • Mitochondrial health

    Lactate · CoQ10 · carnitine

    Systemic mitochondrial function. Efficient mitochondria = enough ATP to repair matrix, contain oxidative stress and support chondrocyte and type I muscle fiber demand.

  • Systemic senescent burden

    SASP markers · p16^INK4a

    Markers associated with the secretory senescent phenotype. They quantify the pressure old cells exert on young tissues through circulating cytokines and metalloproteases.

MRI and X-ray remain indispensable tools — they characterize structural damage and plan surgical intervention. But they only show part of the story. The visible part. The already-consolidated part. What they do not show is the speed at which that damage is being produced, nor the biological context accelerating or decelerating it. That is why modern evaluation integrates structural imaging with systemic biology — and why clinical response stops depending only on the surgeon and starts depending on the whole organism.

Ch. 06 · The new science of joint longevity

Six biological axes that modern medicine integrates for long-term joint health

Aging science — geroscience per Kennedy et al. (Cell 2014) — proposes that chronic diseases share common biological mechanisms. Modulating these general mechanisms can shift the trajectory of multiple organs at once, including the joint system. These are the six axes modern aging medicine integrates into its reading of systemic joint health.

  • Reduce chronic inflammation

    Inflammaging modulation

    Reducing the systemic inflammatory milieu — cytokines, hsCRP, IL-6, TNF-α — unloads cartilage from the continuous catabolic biochemical bombardment. It is the foundation on which every other intervention rests.

  • Optimize metabolism

    Insulin sensitivity · AGEs

    Improving HOMA-IR, HbA1c and lipid profile reduces glucotoxicity on joint collagen, restores IGF-1 reparative signaling, and limits AGE formation that stiffens tissues.

  • Improve mitochondrial function

    ATP · oxidative stress

    Efficient mitochondria provide the ATP needed to synthesize matrix and sustain endogenous antioxidants in the chondrocyte. Mitochondrial health is the energy currency enabling real tissue repair.

  • Preserve muscle mass

    Stabilization · myokines

    Maintaining muscle mass, strength and function reduces direct load on the joint, restores dynamic shock absorption, and sustains secretion of anti-inflammatory myokines that protect cartilage.

  • Optimize hormones

    Anabolic reparative axis

    Maintaining the anabolic hormonal profile (estradiol, testosterone, DHEA, GH/IGF-1, TSH) within healthy ranges sustains the repair capacity of cartilage, bone and muscle. Menopause and andropause are not destiny — they are an intervention window.

  • Global regenerative capacity

    Senescent burden · progenitor cells

    Reducing systemic senescent burden and preserving progenitor cell function (mesenchymal and satellite) extends the window in which tissues can respond to reparative interventions. It is what connects aging biology with real joint health.

What science teaches us today: the hallmarks of aging that converge in the joint

López-Otín, Blasco, Partridge, Serrano and Kroemer published in Cell in 2023 the most cited update of the hallmarks of aging framework — the twelve identifiable biological mechanisms of aging. Five of them are directly related to joint health and form a self-reinforcing cluster: chronic inflammation, cellular senescence, mitochondrial dysfunction, metabolic alterations and declining regeneration. They are not independent processes — they are interconnected, and the presence of one accelerates the others.

Visual summary · López-Otín et al. · Cell · 2023

Five hallmarks of aging that converge in the joint

Each feeds the next. That's why an intervention that modulates only one produces limited responses — and why aging medicine looks at the complete cluster.

  • Chronic inflammation

    Integrative hallmark

    López-Otín 2023 classifies it as an integrative hallmark — it emerges from the others and amplifies them. In the joint it is the unifying factor connecting visceral obesity, senescence, hormones and mitochondrial dysfunction.

  • Cellular senescence

    Antagonistic hallmark

    Senescent cells in the joint secrete SASP — cytokines and metalloproteases — that destroy matrix and propagate senescence. Khosla et al. (Nat Rev Endocrinol 2020) described their role in endocrine and musculoskeletal disease.

  • Mitochondrial dysfunction

    Antagonistic hallmark

    Without enough ATP, the chondrocyte does not synthesize matrix or maintain endogenous antioxidants. Without mitochondrial oxygen, periarticular muscle weakens. Mitochondrial dysfunction is energy lost for repair.

  • Metabolic alterations

    Nutrient-sensing dysregulation

    Hyperinsulinemia and insulin resistance alter mTOR, AMPK and sirtuin pathways — the major nutritional sensors regulating repair, autophagy and cellular survival. What is true for global aging is true for joint aging.

  • Declining tissue regeneration

    Stem cell exhaustion

    Mesenchymal progenitor cells that would normally repair cartilage and muscle become scarce, functionally compromised and senescent. This is the hallmark directly connecting biological aging with the loss of real reparative joint capacity.

Senescence generates inflammation. Inflammation damages mitochondria. Dysfunctional mitochondria produce oxidative stress that triggers senescence. Insulin resistance amplifies all three. Sarcopenia withdraws anti-inflammatory myokine signaling. It is a self-reinforcing system. That is why intervening on a single axis is rarely sufficient — and why modern aging medicine works on the cluster, not the isolated symptom.

Conclusion

Joints do not age in isolation. They are part of an entire organism. Understanding why a joint stops regenerating may be as important as understanding what is happening inside it.

X-ray and MRI capture geometry. Systemic biology captures trajectory. Modern aging medicine integrates both — and that is why a modern joint health evaluation is measured in biomarkers before images, in biological context before Kellgren-Lawrence grades.

Frequently asked questions about joint pain and biological aging

The most common questions when we explain why joint pain is not just wear. Every answer aligns with indexed reference literature: López-Otín 2023 (Cell), Furman 2019 (Nat Med), Jeon 2017 (Nat Med), Coryell 2021 (Nat Rev Rheumatol), Cruz-Jentoft 2019 (Age Ageing), Berenbaum 2013 (Curr Opin Rheumatol).

01

Why can two patients with the same MRI feel pain so differently?

Because joint pain does not originate solely in the cartilage. Intensity and progression depend on systemic biological context: chronic low-grade inflammation (inflammaging), periarticular muscle mass, mitochondrial function, metabolic control, hormonal profile and senescent cell burden.

Two patients with the same radiological finding may have biological ages differing by 10-15 years, opposite inflammatory profiles and repair capacities in entirely different clinical categories.

López-Otín et al. · Cell · 2023
02

What is inflammaging and how does it relate to joint pain?

Inflammaging is the term proposed by Claudio Franceschi (J Gerontol 2014) to describe chronic low-grade inflammation characteristic of aging. Furman et al. (Nature Medicine 2019) consolidated the evidence that it is a shared causal factor in most age-related diseases.

Persistently elevated IL-6, TNF-α, hsCRP, IL-1β degrade cartilage matrix, alter chondrocytes and accelerate joint cellular senescence. Cartilage lives bathed in a hostile milieu — and stops repairing.

Franceschi 2014 · Furman 2019
03

What role do senescent cells play in osteoarthritis?

Jeon et al. (Nature Medicine 2017) demonstrated in post-traumatic osteoarthritis models that local clearance of senescent cells attenuates progression and creates a pro-regenerative environment.

Senescent cells in the joint secrete the SASP phenotype (Senescence-Associated Secretory Phenotype) — a cocktail of cytokines, chemokines and metalloproteases that destroys cartilage matrix and propagates senescence to neighboring cells. Coryell, Diekman and Loeser (Nat Rev Rheumatol 2021) reviewed this mechanism comprehensively.

Jeon 2017 · Coryell 2021
04

What does visceral fat have to do with knee pain?

More than it seems. Visceral fat is not inert tissue — it is an endocrine organ producing pro-inflammatory adipokines: leptin, resistin, IL-6, TNF-α.

Berenbaum, Eymard and Houard (Curr Opin Rheumatol 2013) described how central obesity accelerates osteoarthritis not only through mechanical load but through systemic inflammation. That's why a person with central overweight can have joint pain even in non-load-bearing joints like the hands.

Berenbaum 2013
05

Why does sarcopenia worsen joint pain?

Periarticular muscle is stabilizer, shock absorber and endocrine pump. When muscle mass is lost — sarcopenia, defined per the European EWGSOP2 consensus by Cruz-Jentoft (Age Ageing 2019) — the joint receives more direct load, less dynamic protection, and less anti-inflammatory signaling from myokines (irisin, IL-15) that active muscle releases.

Sarcopenia and osteoarthritis accelerate each other. That's why a joint evaluation without DEXA and ASMI is an incomplete evaluation.

Cruz-Jentoft 2019 EWGSOP2
06

What should be measured in a modern joint health evaluation?

Beyond MRI and X-ray: biological age (DunedinPACE, GlycanAge), body composition by DEXA (appendicular muscle mass, visceral fat, bone mineral density), inflammatory markers (hsCRP, IL-6, ESR), metabolic profile (HOMA-IR, HbA1c, ApoB, Lp(a)), full hormonal profile (free testosterone, estradiol, DHEA-S, IGF-1, TSH), VO₂ Max, grip strength and cartilage matrix biomarkers (CTX-II, COMP).

That is the complete picture structural imaging does not show.

07

Does this mean mechanical injury no longer matters?

No. Biomechanics, prior injuries and structural damage still matter — they are real and measurable factors. What modern science integrates is that those factors act on a biological terrain.

A meniscal injury in a patient with low inflammaging, good muscle mass and preserved mitochondrial function heals differently than the same injury in a patient with insulin resistance, sarcopenia and high senescent burden. The paradigm does not replace mechanics — it complements it.

08

Does Wellness Care treat joint pain?

Wellness Care evaluates the biological context of the patient with joint pain — aging biomarkers, inflammatory profile, body composition, hormones, metabolic and mitochondrial function — and designs individualized systemic optimization protocols.

This page is strictly educational and scientific. The clinical decision about any specific intervention is always medical, individualized, and discussed case-by-case in on-site assessment.

And if that conversation were to include cell or regenerative therapy — mesenchymal stem cells, exosomes, PRP — it is worth reviewing first the 7 international safety criteria every responsible clinic should meet before applying a biological product to a human being. At Wellness Care or anywhere else.

Want to understand the biology of your joint pain?

Start with a modern biomarker evaluation

We evaluate biological age, body composition by DEXA, inflammatory profile, metabolic profile, full hormonal profile, cardiorespiratory capacity, and specific cartilage matrix and senescent burden biomarkers. The complete picture — the one X-ray and MRI do not show. What we decide to do with that picture is always individual clinical conversation.

See advanced biomarker panels